Pharmacologic concentrations of melatonin have diverse influence on differential expressions of angiogenic chemokine genes in different hepatocellular carcinoma cell lines

Biomedicine and Pharmacotherapy

Volumn 64, Issue 10, 2010, Pages 659-662

  Lin, Zu Yau ^a,b   Chuang, Wan Long ^a,b  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Chemokine; Hepatocellular carcinoma; Melatonin

Indexed keywords

AMPHOTERICIN B; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE CHEMOTACTIC PROTEIN 2; INTERLEUKIN 8; MANGANESE SUPEROXIDE DISMUTASE; MELATONIN; MONOCYTE CHEMOTACTIC PROTEIN 1;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG ANTAGONISM; GENE EXPRESSION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; OXIDATIVE STRESS; PRIORITY JOURNAL;

AMIDOHYDROLASES; AMPHOTERICIN B; CARCINOMA, HEPATOCELLULAR; CELL ADHESION MOLECULES; CELL LINE, TUMOR; CHEMOKINES; COLORING AGENTS; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GPI-LINKED PROTEINS; HUMANS; LIVER NEOPLASMS; MELATONIN; OXIDATIVE STRESS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SUPEROXIDE DISMUTASE; TETRAZOLIUM SALTS; THIAZOLES; UP-REGULATION;

EID: 78649866557     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2010.09.006     Document Type: Article

References (29)

1. Hill S.M., Blask D.E. Effects of the pineal hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture. Cancer Res 1988, 48:6121-6126.
2. Korkmaz A., Reiter R.J., Topal T., Manchester L.C., Oter S., Tan D.X. Melatonin: an established antioxidant worthy of use in clinical trials. Mol Med 2009, 15:43-50.
3. Reiter R.J., Tan D.X., Jou M.J., Korkmaz A., Manchester L.C., Paredes S.D. Biogenic amines in the reduction of oxidative stress: melatonin and its metabolites. Neuro Endocrinol Lett 2008, 29:391-398.
4. Gitto E., Romeo C., Reiter R.J., Impellizzeri P., Pesce S., Basile M., et al. Melatonin reduces oxidative stress in surgical neonates. J Pediatr Surg 2004, 39:184-189.
5. Gitto E., Reiter R.J., Cordaro S.P., La Rosa M., Chiurazzi P., Trimarchi G., et al. Oxidative and inflammatory parameters in respiratory distress syndrome of preterm newborns: beneficial effects of melatonin. Am J Perinatol 2004, 21:209-216.
6. Peña C., Rincon J., Pedreanez A., Viera N., Mosquera J. Chemotactic effect of melatonin on leukocytes. J Pineal Res 2007, 43:263-269.
7. Park H.J., Kim H.J., Ra J., Hong S.J., Baik H.H., Park H.K., et al. Melatonin inhibits lipopolysaccharide-induced CC chemokine subfamily gene expression in human peripheral blood mononuclear cells in a microarray analysis. J Pineal Res 2007, 43:121-129.
8. Li J.H., Zhou W., Liu K., Li H.X., Wang L. Melatonin reduces the expression of chemokines in rat with trinitrobenzene sulfonic acid-induced colitis. Saudi Med J 2008, 29:1088-1094.
9. Lissoni P., Barni S., Meregalli S., Fossati V., Cazzaniga M., Esposti D., et al. Modulation of cancer endocrine therapy by melatonin: a phase II study of tamoxifen plus melatonin in metastatic breast cancer patients progressing under tamoxifen alone. Br J Cancer 1995, 71:854-856.
10. Lissoni P., Paolorossi F., Tancini G., Ardizzoia A., Barni S., Brivio F., et al. A phase II study of tamoxifen plus melatonin in metastatic solid tumour patients. Br J Cancer 1996, 74:1466-1468.
11. Lissoni P. Is there a role for melatonin in supportive care?. Support Care Cancer 2002, 10:110-116.
12. Osseni R.A., Rat P., Bogdan A., Warnet J.M., Touitou Y. Evidence of prooxidant and antioxidant action of melatonin on human liver cell line HepG2. Life Sci 2000, 68:387-399.
13. Wölfler A., Caluba H.C., Abuja P.M., Dohr G., Schauenstein K., Liebmann P.M. Prooxidant activity of melatonin promotes fas-induced cell death in human leukemic Jurkat cells. FEBS Lett 2001, 502:127-131.
14. Lin Z.Y., Chuang W.L., Chuang Y.H. Amphotericin B up-regulates angiogenic genes in hepatocellular carcinoma cell lines. Eur J Clin Invest 2009, 39:239-245.
15. Ohta M., Kitadai Y., Tanaka S., Yoshihara M., Yasui W., Mukaida N., et al. Monocyte chemoattractant protein-1 expression correlates with macrophage infiltration and tumor vascularity in human esophageal squamous cell carcinomas. Int J Cancer 2002, 102:220-224.
16. Ohta M., Kitadai Y., Tanaka S., Yoshihara M., Yasui W., Mukaida N., et al. Monocyte chemoattractant protein-1 expression correlates with macrophage infiltration and tumor vascularity in human gastric carcinomas. Int J Oncol 2003, 22:773-778.
17. Strieter R.M., Polverini P.J., Kunkel S.L., Arenberg D.A., Burdick M.D., Kasper J., et al. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem 1995, 270:27348-27357.
18. Strieter R.M., Burdick M.D., Mestas J., Gomperts B., Keane M.P., Belperio J.A. Cancer CXC chemokine networks and tumour angiogenesis. Eur J Cancer 2006, 42:768-778.
19. Melov S. Mitochondrial oxidative stress. Physiologic consequences and potential for a role in aging. Ann N Y Acad Sci 2000, 908:219-225.
20. Martin F.M., Bydlon G., Friedman J.S. SOD2-deficiency sideroblastic anemia and red blood cell oxidative stress. Antioxid Redox Signal 2006, 8:1217-1225.
21. Jang Y.C., Remmen V.H. The mitochondrial theory of aging: insight from transgenic and knockout mouse models. Exp Gerontol 2009, 44:256-260.
22. Berruyer C., Martin F.M., Castellano R., Macone A., Malergue F., Garrido-Urbani S., et al. Vanin-1-/- mice exhibit a glutathione-mediated tissue resistance to oxidative stress. Mol Cell Biol 2004, 24:7214-7224.
23. Lin ZY, Chuang WL. Pharmacologic concentrations of ascorbic acid cause diverse influence on differential expressions of angiogenic chemokine genes in different hepatocellular carcinoma cell lines. Biomed Pharmacother 2010;64:348-51.
24. Martín-Renedo J., Mauriz J.L., Jorquera F., Ruiz-Andrés O., González P., González-Gallego J. Melatonin induces cell cycle arrest and apoptosis in hepatocarcinoma HepG2 cell line. J Pineal Res 2008, 45:532-540.
25. Carbajo-Pescador S., Martín-Renedo J., García-Palomo A., Tuñón M.J., Mauriz J.L., González-Gallego J. Changes in the expression of melatonin receptors induced by melatonin treatment in hepatocarcinoma HepG2 cells. J Pineal Res 2009, 47:330-338.
26. Gijsbers K., Gouwy M., Struyf S., Wuyts A., Proost P., Opdenakker G., et al. GCP-2/CXCL6 synergizes with other endothelial cell-derived chemokines in neutrophil mobilization and is associated with angiogenesis in gastro-intestinal tumors. Exp Cell Res 2005, 303:331-342.
27. Tachibana Y., Nakamoto Y., Mukaida N., Kaneko S. Intrahepatic interleukin-8 production during disease progression of chronic hepatitis C. Cancer Lett 2007, 251:36-42.
28. Rubie C., Frick V.O., Pfeil S., Wagner M., Kollmar O., Kopp B., et al. Correlation of IL-8 with induction, progression and metastatic potential of colorectal cancer. World J Gastroenterol 2007, 13:4996-5002.
29. Benoy I.H., Salgado R., Van Dam P., Geboers K., Van Marck E., Scharpé S., et al. Increased serum interleukin-8 in patients with early and metastatic breast cancer correlates with early dissemination and survival. Clin Cancer Res 2004, 10:7157-7162.